Laurus Labs informs about company updates

17 May 2017 Evaluate

As per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) regulations, 2015, Laurus Labs has informed about the Standalone and Consolidated Audited Financial results of the Company for the quarter and year ended 31.03.2017; Auditors Report on the Standalone and Consolidated Audited Financial results of the Company for the quarter and year ended 31.03.2017; and Declaration regarding audit report with unmodified opinion for the financial year ended 31.03.2017.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

586.40 15.60 (2.73%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.